| 1 | right | 13,212 |
| 2 | paretic | 243 |
| 3 | non-dominant | 109 |
| 4 | nondominant | 99 |
| 5 | contralesional | 84 |
| 6 | ipsilesional | 64 |
| 7 | monomorphic | 60 |
| 8 | occiput | 56 |
| 9 | right/left | 36 |
| 10 | left/right | 28 |
| 11 | non-paretic | 25 |
| 12 | period/left | 24 |
| 13 | contra | 23 |
| 14 | nonparetic | 23 |
| 15 | 'right | 19 |
| 16 | non-working | 18 |
| 17 | mini-flared | 13 |
| 18 | six-helix | 11 |
| 19 | bair | 9 |
| 20 | f-m | 9 |
| 21 | perimembranous | 9 |
| 22 | 'left | 8 |
| 23 | heartware | 8 |
| 24 | perigenual | 7 |
| 25 | stroke-affected | 7 |
| 26 | 30-gy | 6 |
| 27 | gloved | 6 |
| 28 | mesometrial | 6 |
| 29 | period/right | 6 |
| 30 | wilmer | 6 |
| 31 | non-lesioned | 5 |
| 32 | operated-on | 5 |
| 33 | pressure/left | 5 |
| 34 | scleral-fixated | 5 |
| 35 | ventro-medial | 5 |
| 36 | child-turcotte | 4 |
| 37 | coblation-assisted | 4 |
| 38 | deafferented | 4 |
| 39 | evaheart | 4 |
| 40 | fraction-right | 4 |
| 41 | mn-pdt | 4 |
| 42 | nonlesioned | 4 |
| 43 | sidewinder | 4 |
| 44 | α11.3 | 4 |
| 45 | 80-gy | 3 |
| 46 | aptus | 3 |
| 47 | cannabidiol/thc | 3 |
| 48 | food-only | 3 |
| 49 | montenegrin | 3 |
| 50 | nonfractured | 3 |
| 51 | period-right | 3 |
| 52 | stable-labeled | 3 |
| 53 | triphalangeal | 3 |
| 54 | 1-800-quit | 2 |
| 55 | atrio-his | 2 |
| 56 | br-related | 2 |
| 57 | cis/rt | 2 |
| 58 | cognitive-psychosocial | 2 |
| 59 | collateralized | 2 |
| 60 | comparison/control | 2 |
| 61 | cramer-rao | 2 |
| 62 | death/sustained | 2 |
| 63 | dispo | 2 |
| 64 | duruöz | 2 |
| 65 | erlotinib-alone | 2 |
| 66 | hyperextended | 2 |
| 67 | hypertension/right | 2 |
| 68 | juiced | 2 |
| 69 | keraring | 2 |
| 70 | language-dominant | 2 |
| 71 | laparoscopic-induced | 2 |
| 72 | ldhi | 2 |
| 73 | needle-treated | 2 |
| 74 | no-insulin | 2 |
| 75 | nondeviated | 2 |
| 76 | nonleft | 2 |
| 77 | oryctes | 2 |
| 78 | period-left | 2 |
| 79 | placebo/placebo-like | 2 |
| 80 | pole-to-pole | 2 |
| 81 | prp/fat | 2 |
| 82 | rv-to-left | 2 |
| 83 | scleral-sutured | 2 |
| 84 | soc-only | 2 |
| 85 | super-resolved | 2 |
| 86 | t13/l1 | 2 |
| 87 | yindan | 2 |
| 88 | 'oblique | 1 |
| 89 | 'predominantly | 1 |
| 90 | 1200-μg | 1 |
| 91 | 130-degree | 1 |
| 92 | 14,409 | 1 |
| 93 | 17.5-kda | 1 |
| 94 | 17beta-ketol | 1 |
| 95 | 1=very | 1 |
| 96 | 435,394 | 1 |
| 97 | 44-gy | 1 |
| 98 | 6ª | 1 |
| 99 | 6α-amide | 1 |
| 100 | alkyl-aminoethane | 1 |
| 101 | alkylaminoethane | 1 |
| 102 | alpha-cellulose-treated | 1 |
| 103 | anatomically-accurate | 1 |
| 104 | arousal-sensitive | 1 |
| 105 | arrhythmias-frequent | 1 |
| 106 | artery-right | 1 |
| 107 | babystart® | 1 |
| 108 | bacte- | 1 |
| 109 | barkeley | 1 |
| 110 | baso-lateral | 1 |
| 111 | beta-ethanolamine | 1 |
| 112 | better-hearing | 1 |
| 113 | bv-containing | 1 |
| 114 | cannula-injected | 1 |
| 115 | cannula-treated | 1 |
| 116 | cdm+tretinoin | 1 |
| 117 | charged/hydrophobic | 1 |
| 118 | chorio-decidual | 1 |
| 119 | circumflex-perfused | 1 |
| 120 | clinicaltrials.govnct00513500 | 1 |
| 121 | control/unaffected | 1 |
| 122 | coronary-specific | 1 |
| 123 | cpvi+rl+posterior | 1 |
| 124 | cupid-bow | 1 |
| 125 | death/major | 1 |
| 126 | desipramine-citalopram | 1 |
| 127 | desipramine-desipramine | 1 |
| 128 | device-treated | 1 |
| 129 | dh31-expressing | 1 |
| 130 | dhp-only | 1 |
| 131 | dimethylaminoethane | 1 |
| 132 | drug-retailing | 1 |
| 133 | enrich- | 1 |
| 134 | ethyl-group | 1 |
| 135 | eumulgin | 1 |
| 136 | expulsion/left | 1 |
| 137 | f231 | 1 |
| 138 | five-helix | 1 |
| 139 | folfiri-containing | 1 |
| 140 | fraction×left | 1 |
| 141 | fs+lf | 1 |
| 142 | fs-containing | 1 |
| 143 | gln134 | 1 |
| 144 | hapmed | 1 |
| 145 | in-left | 1 |
| 146 | injury-mediated | 1 |
| 147 | intrapartumare | 1 |
| 148 | ipl-only | 1 |
| 149 | lateral-superior | 1 |
| 150 | long-and | 1 |
| 151 | lvf/right | 1 |
| 152 | lysine-17 | 1 |
| 153 | mass-labeled | 1 |
| 154 | mdi/ad | 1 |
| 155 | medumat | 1 |
| 156 | monomorphie | 1 |
| 157 | mph-containing | 1 |
| 158 | neglect-typical | 1 |
| 159 | neurx | 1 |
| 160 | niacin-pretreated | 1 |
| 161 | no-lead-in | 1 |
| 162 | non-approach | 1 |
| 163 | non-csd | 1 |
| 164 | non-defective | 1 |
| 165 | non-pdpt | 1 |
| 166 | non-software | 1 |
| 167 | noncrossbite | 1 |
| 168 | noninked | 1 |
| 169 | onartuzumab-containing | 1 |
| 170 | passive-tension | 1 |
| 171 | period-to-left | 1 |
| 172 | peroid/left | 1 |
| 173 | perseveration-related | 1 |
| 174 | pld-alone | 1 |
| 175 | post-ventricular | 1 |
| 176 | power-microdebrider-assisted | 1 |
| 177 | preliminary-year | 1 |
| 178 | pressure-right | 1 |
| 179 | pseudo-points | 1 |
| 180 | quinine/doxycyline | 1 |
| 181 | rate-right | 1 |
| 182 | reddest | 1 |
| 183 | retrolenticular | 1 |
| 184 | reward-activated | 1 |
| 185 | reward-evaluating | 1 |
| 186 | reward-responsive | 1 |
| 187 | rhegf-applied | 1 |
| 188 | righhand | 1 |
| 189 | right-lateralised | 1 |
| 190 | righthand | 1 |
| 191 | room-exit | 1 |
| 192 | rotenone-insensitive | 1 |
| 193 | sadness-induced | 1 |
| 194 | sca-treated | 1 |
| 195 | septum-to-right | 1 |
| 196 | sericin-treated | 1 |
| 197 | shaolin | 1 |
| 198 | shoulders/upper | 1 |
| 199 | sinusoidal-venous | 1 |
| 200 | spontaneously-beating | 1 |
| 201 | tactile-only | 1 |
| 202 | tae-wook | 1 |
| 203 | também | 1 |
| 204 | thpe-treated | 1 |
| 205 | time/left | 1 |
| 206 | triantafillou | 1 |
| 207 | tu-negative | 1 |
| 208 | uva1-treated | 1 |
| 209 | ventral-skin | 1 |
| 210 | vmpt-vt/vmp | 1 |
| 211 | µg/each | 1 |
| 212 | ¹³c-labelled | 1 |
| 1 | 'left | 8 |
| 2 | 'oblique | 1 |
| 3 | 'predominantly | 1 |
| 4 | 'right | 19 |
| 5 | 1-800-quit | 2 |
| 6 | 1200-μg | 1 |
| 7 | 130-degree | 1 |
| 8 | 14,409 | 1 |
| 9 | 17.5-kda | 1 |
| 10 | 17beta-ketol | 1 |
| 11 | 1=very | 1 |
| 12 | 30-gy | 6 |
| 13 | 435,394 | 1 |
| 14 | 44-gy | 1 |
| 15 | 6ª | 1 |
| 16 | 6α-amide | 1 |
| 17 | 80-gy | 3 |
| 18 | alkyl-aminoethane | 1 |
| 19 | alkylaminoethane | 1 |
| 20 | alpha-cellulose-treated | 1 |
| 21 | anatomically-accurate | 1 |
| 22 | aptus | 3 |
| 23 | arousal-sensitive | 1 |
| 24 | arrhythmias-frequent | 1 |
| 25 | artery-right | 1 |
| 26 | atrio-his | 2 |
| 27 | babystart® | 1 |
| 28 | bacte- | 1 |
| 29 | bair | 9 |
| 30 | barkeley | 1 |
| 31 | baso-lateral | 1 |
| 32 | beta-ethanolamine | 1 |
| 33 | better-hearing | 1 |
| 34 | br-related | 2 |
| 35 | bv-containing | 1 |
| 36 | cannabidiol/thc | 3 |
| 37 | cannula-injected | 1 |
| 38 | cannula-treated | 1 |
| 39 | cdm+tretinoin | 1 |
| 40 | charged/hydrophobic | 1 |
| 41 | child-turcotte | 4 |
| 42 | chorio-decidual | 1 |
| 43 | circumflex-perfused | 1 |
| 44 | cis/rt | 2 |
| 45 | clinicaltrials.govnct00513500 | 1 |
| 46 | coblation-assisted | 4 |
| 47 | cognitive-psychosocial | 2 |
| 48 | collateralized | 2 |
| 49 | comparison/control | 2 |
| 50 | contra | 23 |
| 51 | contralesional | 84 |
| 52 | control/unaffected | 1 |
| 53 | coronary-specific | 1 |
| 54 | cpvi+rl+posterior | 1 |
| 55 | cramer-rao | 2 |
| 56 | cupid-bow | 1 |
| 57 | deafferented | 4 |
| 58 | death/major | 1 |
| 59 | death/sustained | 2 |
| 60 | desipramine-citalopram | 1 |
| 61 | desipramine-desipramine | 1 |
| 62 | device-treated | 1 |
| 63 | dh31-expressing | 1 |
| 64 | dhp-only | 1 |
| 65 | dimethylaminoethane | 1 |
| 66 | dispo | 2 |
| 67 | drug-retailing | 1 |
| 68 | duruöz | 2 |
| 69 | enrich- | 1 |
| 70 | erlotinib-alone | 2 |
| 71 | ethyl-group | 1 |
| 72 | eumulgin | 1 |
| 73 | evaheart | 4 |
| 74 | expulsion/left | 1 |
| 75 | f-m | 9 |
| 76 | f231 | 1 |
| 77 | five-helix | 1 |
| 78 | folfiri-containing | 1 |
| 79 | food-only | 3 |
| 80 | fraction-right | 4 |
| 81 | fraction×left | 1 |
| 82 | fs+lf | 1 |
| 83 | fs-containing | 1 |
| 84 | gln134 | 1 |
| 85 | gloved | 6 |
| 86 | hapmed | 1 |
| 87 | heartware | 8 |
| 88 | hyperextended | 2 |
| 89 | hypertension/right | 2 |
| 90 | in-left | 1 |
| 91 | injury-mediated | 1 |
| 92 | intrapartumare | 1 |
| 93 | ipl-only | 1 |
| 94 | ipsilesional | 64 |
| 95 | juiced | 2 |
| 96 | keraring | 2 |
| 97 | language-dominant | 2 |
| 98 | laparoscopic-induced | 2 |
| 99 | lateral-superior | 1 |
| 100 | ldhi | 2 |
| 101 | left/right | 28 |
| 102 | long-and | 1 |
| 103 | lvf/right | 1 |
| 104 | lysine-17 | 1 |
| 105 | mass-labeled | 1 |
| 106 | mdi/ad | 1 |
| 107 | medumat | 1 |
| 108 | mesometrial | 6 |
| 109 | mini-flared | 13 |
| 110 | mn-pdt | 4 |
| 111 | monomorphic | 60 |
| 112 | monomorphie | 1 |
| 113 | montenegrin | 3 |
| 114 | mph-containing | 1 |
| 115 | needle-treated | 2 |
| 116 | neglect-typical | 1 |
| 117 | neurx | 1 |
| 118 | niacin-pretreated | 1 |
| 119 | no-insulin | 2 |
| 120 | no-lead-in | 1 |
| 121 | non-approach | 1 |
| 122 | non-csd | 1 |
| 123 | non-defective | 1 |
| 124 | non-dominant | 109 |
| 125 | non-lesioned | 5 |
| 126 | non-paretic | 25 |
| 127 | non-pdpt | 1 |
| 128 | non-software | 1 |
| 129 | non-working | 18 |
| 130 | noncrossbite | 1 |
| 131 | nondeviated | 2 |
| 132 | nondominant | 99 |
| 133 | nonfractured | 3 |
| 134 | noninked | 1 |
| 135 | nonleft | 2 |
| 136 | nonlesioned | 4 |
| 137 | nonparetic | 23 |
| 138 | occiput | 56 |
| 139 | onartuzumab-containing | 1 |
| 140 | operated-on | 5 |
| 141 | oryctes | 2 |
| 142 | paretic | 243 |
| 143 | passive-tension | 1 |
| 144 | perigenual | 7 |
| 145 | perimembranous | 9 |
| 146 | period-left | 2 |
| 147 | period-right | 3 |
| 148 | period-to-left | 1 |
| 149 | period/left | 24 |
| 150 | period/right | 6 |
| 151 | peroid/left | 1 |
| 152 | perseveration-related | 1 |
| 153 | placebo/placebo-like | 2 |
| 154 | pld-alone | 1 |
| 155 | pole-to-pole | 2 |
| 156 | post-ventricular | 1 |
| 157 | power-microdebrider-assisted | 1 |
| 158 | preliminary-year | 1 |
| 159 | pressure-right | 1 |
| 160 | pressure/left | 5 |
| 161 | prp/fat | 2 |
| 162 | pseudo-points | 1 |
| 163 | quinine/doxycyline | 1 |
| 164 | rate-right | 1 |
| 165 | reddest | 1 |
| 166 | retrolenticular | 1 |
| 167 | reward-activated | 1 |
| 168 | reward-evaluating | 1 |
| 169 | reward-responsive | 1 |
| 170 | rhegf-applied | 1 |
| 171 | righhand | 1 |
| 172 | right | 13,212 |
| 173 | right-lateralised | 1 |
| 174 | right/left | 36 |
| 175 | righthand | 1 |
| 176 | room-exit | 1 |
| 177 | rotenone-insensitive | 1 |
| 178 | rv-to-left | 2 |
| 179 | sadness-induced | 1 |
| 180 | sca-treated | 1 |
| 181 | scleral-fixated | 5 |
| 182 | scleral-sutured | 2 |
| 183 | septum-to-right | 1 |
| 184 | sericin-treated | 1 |
| 185 | shaolin | 1 |
| 186 | shoulders/upper | 1 |
| 187 | sidewinder | 4 |
| 188 | sinusoidal-venous | 1 |
| 189 | six-helix | 11 |
| 190 | soc-only | 2 |
| 191 | spontaneously-beating | 1 |
| 192 | stable-labeled | 3 |
| 193 | stroke-affected | 7 |
| 194 | super-resolved | 2 |
| 195 | t13/l1 | 2 |
| 196 | tactile-only | 1 |
| 197 | tae-wook | 1 |
| 198 | também | 1 |
| 199 | thpe-treated | 1 |
| 200 | time/left | 1 |
| 201 | triantafillou | 1 |
| 202 | triphalangeal | 3 |
| 203 | tu-negative | 1 |
| 204 | uva1-treated | 1 |
| 205 | ventral-skin | 1 |
| 206 | ventro-medial | 5 |
| 207 | vmpt-vt/vmp | 1 |
| 208 | wilmer | 6 |
| 209 | yindan | 2 |
| 210 | µg/each | 1 |
| 211 | ¹³c-labelled | 1 |
| 212 | α11.3 | 4 |
| 1 | bacte- | 1 |
| 2 | enrich- | 1 |
| 3 | clinicaltrials.govnct00513500 | 1 |
| 4 | f231 | 1 |
| 5 | t13/l1 | 2 |
| 6 | α11.3 | 4 |
| 7 | gln134 | 1 |
| 8 | 435,394 | 1 |
| 9 | lysine-17 | 1 |
| 10 | 14,409 | 1 |
| 11 | 17.5-kda | 1 |
| 12 | contra | 23 |
| 13 | cannabidiol/thc | 3 |
| 14 | charged/hydrophobic | 1 |
| 15 | coronary-specific | 1 |
| 16 | monomorphic | 60 |
| 17 | paretic | 243 |
| 18 | non-paretic | 25 |
| 19 | nonparetic | 23 |
| 20 | mdi/ad | 1 |
| 21 | juiced | 2 |
| 22 | laparoscopic-induced | 2 |
| 23 | sadness-induced | 1 |
| 24 | hyperextended | 2 |
| 25 | rhegf-applied | 1 |
| 26 | noninked | 1 |
| 27 | stable-labeled | 3 |
| 28 | mass-labeled | 1 |
| 29 | ¹³c-labelled | 1 |
| 30 | hapmed | 1 |
| 31 | death/sustained | 2 |
| 32 | non-lesioned | 5 |
| 33 | nonlesioned | 4 |
| 34 | mini-flared | 13 |
| 35 | nonfractured | 3 |
| 36 | scleral-sutured | 2 |
| 37 | right-lateralised | 1 |
| 38 | circumflex-perfused | 1 |
| 39 | uva1-treated | 1 |
| 40 | sca-treated | 1 |
| 41 | cannula-treated | 1 |
| 42 | device-treated | 1 |
| 43 | needle-treated | 2 |
| 44 | thpe-treated | 1 |
| 45 | alpha-cellulose-treated | 1 |
| 46 | sericin-treated | 1 |
| 47 | niacin-pretreated | 1 |
| 48 | injury-mediated | 1 |
| 49 | nondeviated | 2 |
| 50 | perseveration-related | 1 |
| 51 | br-related | 2 |
| 52 | reward-activated | 1 |
| 53 | scleral-fixated | 5 |
| 54 | stroke-affected | 7 |
| 55 | control/unaffected | 1 |
| 56 | cannula-injected | 1 |
| 57 | deafferented | 4 |
| 58 | coblation-assisted | 4 |
| 59 | power-microdebrider-assisted | 1 |
| 60 | super-resolved | 2 |
| 61 | gloved | 6 |
| 62 | collateralized | 2 |
| 63 | long-and | 1 |
| 64 | righhand | 1 |
| 65 | righthand | 1 |
| 66 | non-csd | 1 |
| 67 | 6α-amide | 1 |
| 68 | 130-degree | 1 |
| 69 | monomorphie | 1 |
| 70 | placebo/placebo-like | 2 |
| 71 | pole-to-pole | 2 |
| 72 | alkyl-aminoethane | 1 |
| 73 | dimethylaminoethane | 1 |
| 74 | alkylaminoethane | 1 |
| 75 | quinine/doxycyline | 1 |
| 76 | beta-ethanolamine | 1 |
| 77 | desipramine-desipramine | 1 |
| 78 | erlotinib-alone | 2 |
| 79 | pld-alone | 1 |
| 80 | intrapartumare | 1 |
| 81 | non-software | 1 |
| 82 | heartware | 8 |
| 83 | anatomically-accurate | 1 |
| 84 | noncrossbite | 1 |
| 85 | child-turcotte | 4 |
| 86 | 'oblique | 1 |
| 87 | reward-responsive | 1 |
| 88 | tu-negative | 1 |
| 89 | non-defective | 1 |
| 90 | arousal-sensitive | 1 |
| 91 | rotenone-insensitive | 1 |
| 92 | fs+lf | 1 |
| 93 | non-working | 18 |
| 94 | drug-retailing | 1 |
| 95 | onartuzumab-containing | 1 |
| 96 | mph-containing | 1 |
| 97 | folfiri-containing | 1 |
| 98 | fs-containing | 1 |
| 99 | bv-containing | 1 |
| 100 | better-hearing | 1 |
| 101 | keraring | 2 |
| 102 | dh31-expressing | 1 |
| 103 | spontaneously-beating | 1 |
| 104 | reward-evaluating | 1 |
| 105 | 1200-μg | 1 |
| 106 | µg/each | 1 |
| 107 | non-approach | 1 |
| 108 | ldhi | 2 |
| 109 | tae-wook | 1 |
| 110 | neglect-typical | 1 |
| 111 | triphalangeal | 3 |
| 112 | cognitive-psychosocial | 2 |
| 113 | ventro-medial | 5 |
| 114 | mesometrial | 6 |
| 115 | contralesional | 84 |
| 116 | ipsilesional | 64 |
| 117 | baso-lateral | 1 |
| 118 | chorio-decidual | 1 |
| 119 | perigenual | 7 |
| 120 | comparison/control | 2 |
| 121 | 17beta-ketol | 1 |
| 122 | f-m | 9 |
| 123 | desipramine-citalopram | 1 |
| 124 | também | 1 |
| 125 | yindan | 2 |
| 126 | no-lead-in | 1 |
| 127 | eumulgin | 1 |
| 128 | ventral-skin | 1 |
| 129 | shaolin | 1 |
| 130 | no-insulin | 2 |
| 131 | cdm+tretinoin | 1 |
| 132 | montenegrin | 3 |
| 133 | operated-on | 5 |
| 134 | passive-tension | 1 |
| 135 | cramer-rao | 2 |
| 136 | dispo | 2 |
| 137 | vmpt-vt/vmp | 1 |
| 138 | ethyl-group | 1 |
| 139 | preliminary-year | 1 |
| 140 | post-ventricular | 1 |
| 141 | retrolenticular | 1 |
| 142 | sidewinder | 4 |
| 143 | wilmer | 6 |
| 144 | shoulders/upper | 1 |
| 145 | bair | 9 |
| 146 | lateral-superior | 1 |
| 147 | cpvi+rl+posterior | 1 |
| 148 | death/major | 1 |
| 149 | oryctes | 2 |
| 150 | atrio-his | 2 |
| 151 | pseudo-points | 1 |
| 152 | perimembranous | 9 |
| 153 | sinusoidal-venous | 1 |
| 154 | aptus | 3 |
| 155 | prp/fat | 2 |
| 156 | medumat | 1 |
| 157 | mn-pdt | 4 |
| 158 | 'left | 8 |
| 159 | period-left | 2 |
| 160 | in-left | 1 |
| 161 | period-to-left | 1 |
| 162 | rv-to-left | 2 |
| 163 | peroid/left | 1 |
| 164 | period/left | 24 |
| 165 | time/left | 1 |
| 166 | pressure/left | 5 |
| 167 | expulsion/left | 1 |
| 168 | right/left | 36 |
| 169 | nonleft | 2 |
| 170 | fraction×left | 1 |
| 171 | right | 13,212 |
| 172 | 'right | 19 |
| 173 | period-right | 3 |
| 174 | pressure-right | 1 |
| 175 | rate-right | 1 |
| 176 | fraction-right | 4 |
| 177 | septum-to-right | 1 |
| 178 | artery-right | 1 |
| 179 | period/right | 6 |
| 180 | lvf/right | 1 |
| 181 | hypertension/right | 2 |
| 182 | left/right | 28 |
| 183 | 1-800-quit | 2 |
| 184 | room-exit | 1 |
| 185 | language-dominant | 2 |
| 186 | non-dominant | 109 |
| 187 | nondominant | 99 |
| 188 | arrhythmias-frequent | 1 |
| 189 | non-pdpt | 1 |
| 190 | cis/rt | 2 |
| 191 | evaheart | 4 |
| 192 | reddest | 1 |
| 193 | occiput | 56 |
| 194 | triantafillou | 1 |
| 195 | cupid-bow | 1 |
| 196 | five-helix | 1 |
| 197 | six-helix | 11 |
| 198 | neurx | 1 |
| 199 | barkeley | 1 |
| 200 | 30-gy | 6 |
| 201 | 80-gy | 3 |
| 202 | 44-gy | 1 |
| 203 | soc-only | 2 |
| 204 | food-only | 3 |
| 205 | tactile-only | 1 |
| 206 | ipl-only | 1 |
| 207 | dhp-only | 1 |
| 208 | 'predominantly | 1 |
| 209 | 1=very | 1 |
| 210 | duruöz | 2 |
| 211 | 6ª | 1 |
| 212 | babystart® | 1 |